| Company/Division name | Moderna Inc. |
| Type of work | Manufacturing |
| Reshoring category: | Reshoring |
| Year reshoring announced: | 2020 |
| Year reshoring implemented or to be implemented: | 2020 |
| Domestically, the work will be done: | Outsourced |
| City reshored to: | Cambridge |
| State(s) reshored to: | MA |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| Product(s) reshored | covid-19 vaccine, mRNA-1273 |
| What domestic positive factors made reshoring more attractive? | Government Incentives, Impact on domestic economy, covid-19 |
| Government Incentive dollar amount: | $483 milliion |
